Almost 40% of shareholders vote down Novartis board package at AGM after first ever say-on-pay

AGM is first ever advisory vote on remuneration following investor campaign.

Almost 40% of shareholders at Novartis, the giant Swiss pharma company, today (February 22) voted against the company’s board pay after a vocal investor campaign against the CHF25m (€19.4m) market value of the package handed last year to board chairman, Daniel Vasella, and the CH…

You must have a SUBSCRIPTION or FREE TRIAL to view this PAID content.

Already got a Subscription or Free Trial?

Login here.

Not got a Subscription or Free Trial?

Sign up for a Free Trial here to access this PAID content.

One Free Trial per user; if your Free Trial has expired, please email subs@responsible-investor.com.

  • tagged with:
  • none
Copyright © 2021 RGM.